TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 10392221

Group type: EXPERIMENTAL
Intervention: Relaxing music in a quiet, restful environment
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Quiet, restful environment without music (attention)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Treatment as usual (control)
Number of subjects: 45
Study: 8561538

Group type: EXPERIMENTAL
Intervention: Intermittent warm blood cardioplegia
Number of subjects: 52

Group type: COMPARATOR
Intervention: Intermittent cold blood cardioplegia
Number of subjects: 52
Study: 1914086

Group type: EXPERIMENTAL
Intervention: Mitozantrone and prednimustine (12 mg/m2 on day 1 and 130 mg/m2 orally on days 1-5, repeated every 4 weeks)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Mitozantrone and prednimustine
Number of subjects: 34
Study: 6885201

Group type: EXPERIMENTAL
Intervention: 250‐mg naproxen tablet I from AFI
Number of subjects: 12

Group type: COMPARATOR
Intervention: 250‐mg naproxen tablet II Naprosyn
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Both tablet formulations
Number of subjects: 12
Study: 31759769

Group type: EXPERIMENTAL
Intervention: Subjects with relatively high fasting insulin (RHI)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Subjects with relatively low fasting insulin (RLI)
Number of subjects: 28
Study: 29602570

Group type: EXPERIMENTAL
Intervention: Adalimumab (ADA) therapy optimization
Number of subjects: 65

Group type: COMPARATOR
Intervention: Nonoptimized Adalimumab (ADA) therapy
Number of subjects: 65
Study: 26316220

Group type: EXPERIMENTAL
Intervention: Mandrax use
Number of subjects: 121
Study: 24777708

Group type: EXPERIMENTAL
Intervention: Aflibercept
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bevacizumab (ABC study as-needed)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bevacizumab (CATT study PRN)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bevacizumab (CATT study 1×/month)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ranibizumab (PRN)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ranibizumab (1×/month)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 0
Study: 22709772

Group type: EXPERIMENTAL
Intervention: WEV+ (daily self-monitoring of body weight, step count, F/V intake, and 16 fl oz of water before each main meal)
Number of subjects: 40

Group type: COMPARATOR
Intervention: WEV (daily self-monitoring of body weight, step count, and F/V intake)
Number of subjects: 40
Study: 20626054

Group type: EXPERIMENTAL
Intervention: Modulated middle-frequency electrical stimulation treatment for 20 min twice a week for 12 consecutive weeks at the Zusanli (ST36) and Sanyinjiao (SP6) acupoints
Number of subjects: 41

Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 41
Study: 17517341

Group type: EXPERIMENTAL
Intervention: Latitude Patient Management System (remote active monitoring)
Number of subjects: 1000
Study: 16163624

Group type: EXPERIMENTAL
Intervention: Artesunate plus amodiaquine (ASAQ) for 3 days
Number of subjects: 408

Group type: COMPARATOR
Intervention: Artemether-lumefantrine (AL) for 3 days
Number of subjects: 408
Study: 12429672

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training
Number of subjects: 228

Group type: COMPARATOR
Intervention: Stretching (control)
Number of subjects: 228
Study: 10707104

Group type: EXPERIMENTAL
Intervention: 100 mg miltefosine/day for 28 days
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 150 mg miltefosine/day for 28 days
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 200 mg miltefosine/day for 28 days
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 100 mg miltefosine/day for 7-17 days
Number of subjects: 60
Study: 7488573

Group type: EXPERIMENTAL
Intervention: Phacoemulsification surgery
Number of subjects: 50

Group type: COMPARATOR
Intervention: Extracapsular surgery
Number of subjects: 50
Study: 2285202

Group type: EXPERIMENTAL
Intervention: Prednisone (1 mg/kg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Prednisolone sodium metasulfobenzoate (Solupred) (1 mg/kg)
Number of subjects: 8
Study: 6117261

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 23

Group type: COMPARATOR
Intervention: CAD (Clonidine or Alpha Methyldopa)
Number of subjects: 23
Study: 30561087

Group type: EXPERIMENTAL
Intervention: One session panretinal photocoagulation (SS-PRP)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Four monthly sessions panretinal photocoagulation (MS-PRP)
Number of subjects: 97
Study: 28970614

Group type: EXPERIMENTAL
Intervention: Simulated patients counseling
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional instruction
Number of subjects: 0
Study: 26870678

Group type: EXPERIMENTAL
Intervention: Dragons blood cream
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo cream
Number of subjects: 60
Study: 25096691

Group type: EXPERIMENTAL
Intervention: High-protein enteral nutrition enriched with immune-modulating nutrients (IMHP)
Number of subjects: 301

Group type: COMPARATOR
Intervention: Standard high-protein enteral nutrition (HP)
Number of subjects: 301
Study: 23131367

Group type: EXPERIMENTAL
Intervention: Tango dance
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Mindfulness meditation
Number of subjects: 97

Group type: COMPARATOR
Intervention: Waiting-list control
Number of subjects: 97
Study: 19542876

Group type: EXPERIMENTAL
Intervention: Extraoral approach
Number of subjects: 58

Group type: COMPARATOR
Intervention: Intraoral method
Number of subjects: 58
Study: 17321311

Group type: EXPERIMENTAL
Intervention: Immediate circumcision
Number of subjects: 4996

Group type: COMPARATOR
Intervention: Circumcision delayed for 24 months (Control)
Number of subjects: 4996

Group type: EXPERIMENTAL
Intervention: As-treated analysis
Number of subjects: 4996

Group type: EXPERIMENTAL
Intervention: Kaplan-Meier time-to-HIV-detection as-treated analysis
Number of subjects: 4996

Group type: EXPERIMENTAL
Intervention: Moderate or severe adverse events
Number of subjects: 4996
Study: 15603606

Group type: EXPERIMENTAL
Intervention: Use of video-phones for symptom management
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Use of video-phones for quality of life
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Use of video-phones for cost
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Use of video-phones for readiness to use technology
Number of subjects: 320
Study: 12421024

Group type: EXPERIMENTAL
Intervention: 0.6 g omega-3 fatty acids (Maxigard) twice daily
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo with diabetic diet
Number of subjects: 65
Study: 9467537

Group type: EXPERIMENTAL
Intervention: Midodrine (5 mg orally, 30 min before breakfast)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Octreotide (0.5 microgram/kg) after midodrine
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Midodrine (10 mg)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Octreotide (1.0 microgram/kg)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Combination of midodrine and octreotide
Number of subjects: 16
Study: 8008792

Group type: EXPERIMENTAL
Intervention: Foot cold pressor task
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Forehead cold pressor task
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-pain stimulus
Number of subjects: 0
Study: 2643356

Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 1089368

Group type: EXPERIMENTAL
Intervention: Diethylcarbamazine
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 31373701

Group type: EXPERIMENTAL
Intervention: Naltrexone 50 mg
Number of subjects: 194

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 194

Group type: COMPARATOR
Intervention: Naltrexone and Placebo
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Reduction in drinking
Number of subjects: 194
Study: 28723596

Group type: EXPERIMENTAL
Intervention: Assertiveness group training conducted over 10 sessions
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 48
Study: 25293355

Group type: EXPERIMENTAL
Intervention: Preoperative microcoil localization
Number of subjects: 60

Group type: COMPARATOR
Intervention: No localization
Number of subjects: 60
Study: 23108628

Group type: EXPERIMENTAL
Intervention: Methylprednisolone (40-80 mg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 21646002

Group type: EXPERIMENTAL
Intervention: Adjuvant radiotherapy to the breast
Number of subjects: 1014

Group type: EXPERIMENTAL
Intervention: Current smoking status
Number of subjects: 1014

Group type: EXPERIMENTAL
Intervention: Post-surgical cosmesis
Number of subjects: 1014

Group type: EXPERIMENTAL
Intervention: Postoperative infection requiring antibiotics
Number of subjects: 1014
Study: 19635302

Group type: EXPERIMENTAL
Intervention: Erythropoietin (Epo) 200 units kg(‐1) d(‐1) for 14 days
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Erythropoietin (Epo)
Number of subjects: 20
Study: 16987465

Group type: EXPERIMENTAL
Intervention: Lopinavir/ritonavir (LPV/r) monotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Triple therapy
Number of subjects: 0
Study: 15173402

Group type: EXPERIMENTAL
Intervention: 0.75 g/100 g free phytosterols in gerbil diet
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Phytosterol-enriched tortilla chips providing 1.5 g/d
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group with no phytosterols in gerbil diet
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group with tortilla chips providing 0 g/d phytosterols
Number of subjects: 33
Study: 11420737

Group type: EXPERIMENTAL
Intervention: Gel padded glove
Number of subjects: 6

Group type: COMPARATOR
Intervention: No glove (control)
Number of subjects: 6
Study: 9021621

Group type: EXPERIMENTAL
Intervention: DVA/Seattle Footwear System with cork insole
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: DVA/Seattle Footwear System with polyurethane insole
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: DVA/Seattle Footwear System
Number of subjects: 24
Study: 8099818

Group type: EXPERIMENTAL
Intervention: Cetirizine (10 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Loratadine (10 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 3321313

Group type: EXPERIMENTAL
Intervention: Pondocillin cocoa‐peppermint mixture
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Pondocillin banana mixture
Number of subjects: 84
Study: 29649054

Group type: EXPERIMENTAL
Intervention: Textured insole with physical therapy for 6 weeks
Number of subjects: 10

Group type: COMPARATOR
Intervention: Physical therapy only for 6 weeks
Number of subjects: 10
Study: 27987397

Group type: EXPERIMENTAL
Intervention: Prophylactic Amoxicillin‐Clavulanic acid 1.2g every 8h
Number of subjects: 60

Group type: COMPARATOR
Intervention: Clinically-driven antibiotics
Number of subjects: 60
Study: 26185896

Group type: EXPERIMENTAL
Intervention: Intervention: Use of stainless steel tableware as meal boxes for each meal during the trial.
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control: Carrying an empty bag during the trial.
Number of subjects: 16
Study: 24167479

Group type: EXPERIMENTAL
Intervention: Glucose drink (elevated BGC by approx. 1.5 mmol/l)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo drink (normal BGC range)
Number of subjects: 0
Study: 21951607

Group type: EXPERIMENTAL
Intervention: BMAC (bone marrow-derived stem cells)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo (peripheral blood)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: BMAC
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 18504482

Group type: EXPERIMENTAL
Intervention: Random urine protein-creatinine ratio with a cut-off greater than 1.14
Number of subjects: 120

Group type: COMPARATOR
Intervention: 24-hour urine protein collection (gold standard)
Number of subjects: 120
Study: 16582059

Group type: EXPERIMENTAL
Intervention: Minimal contact psychotherapy plus usual care
Number of subjects: 216

Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 216
Study: 12736280

Group type: EXPERIMENTAL
Intervention: High-dose therapy with autologous stem-cell transplant
Number of subjects: 407

Group type: COMPARATOR
Intervention: Standard conventional-dose combination chemotherapy
Number of subjects: 407
Study: 10695838

Group type: EXPERIMENTAL
Intervention: Disulfiram during the first month of treatment
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Psychopharmacological treatment
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Therapists with a high conceptual level (empathetic and reflective listening)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Matching of patients with the structure of treatment
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Completion of the motivation phase and active treatment phase
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Age below 40
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Presence of family and social problems
Number of subjects: 150
Study: 9126517

Group type: EXPERIMENTAL
Intervention: Interest in epidemiology
Number of subjects: 376

Group type: EXPERIMENTAL
Intervention: < or = 5 or > or = 20 years seniority
Number of subjects: 376

Group type: COMPARATOR
Intervention: Interest in local epidemiological surveys
Number of subjects: 376

Group type: COMPARATOR
Intervention: Previous experience with other surveillance networks
Number of subjects: 376

Group type: COMPARATOR
Intervention: Computing experience, having a medical secretary, feeling of being a 'public health actor', desire to belong to a GPs' network
Number of subjects: 376
Study: 1608318

Group type: EXPERIMENTAL
Intervention: Droperidol 50 micrograms/kg (iv)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Metoclopramide 0.15 mg/kg (iv)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Ephedrine 0.5 mg/kg (im)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Ephedrine 1 mg/kg (im)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Normal saline (iv) control
Number of subjects: 100
Study: 3874972

Group type: EXPERIMENTAL
Intervention: Summary Time‐Oriented Record (STOR)
Number of subjects: 514

Group type: COMPARATOR
Intervention: Standard Medical Record (MR)
Number of subjects: 514

Group type: COMPARATOR
Intervention: Full paper record option
Number of subjects: 514
Study: 30834611

Group type: EXPERIMENTAL
Intervention: Transvenous phrenic nerve stimulation (remedē System)
Number of subjects: 151
Study: 29498884

Group type: EXPERIMENTAL
Intervention: Anatomic ACLR with intact menisci
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Anatomic ACLR with medial meniscal tears
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Anatomic ACLR with lateral meniscal tears
Number of subjects: 49
Study: 26920611

Group type: EXPERIMENTAL
Intervention: β-blocker therapy (various types including carvedilol, metoprolol succinate, bisoprolol, atenolol, metoprolol tartrate)
Number of subjects: 10696

Group type: COMPARATOR
Intervention: No β-blocker therapy
Number of subjects: 10696

Group type: EXPERIMENTAL
Intervention: Patients discharged on 50% of target dose or greater
Number of subjects: 10696
Study: 25174952

Group type: EXPERIMENTAL
Intervention: Oral nicorandil 20 mg once daily for 1 week before and 6 months after PCI
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 23025138

Group type: EXPERIMENTAL
Intervention: Multidisciplinary reconditioning program
Number of subjects: 33

Group type: COMPARATOR
Intervention: Current standard of care for low back pain
Number of subjects: 33
Study: 20958143

Group type: COMPARATOR
Intervention: Lidocaine solution for inhalation (LSI; 40 mg twice daily; eFlow nebulizer)
Number of subjects: 268

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 268
Study: 17333313

Group type: EXPERIMENTAL
Intervention: Subjectively pleasant music
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Sad music
Number of subjects: 29

Group type: COMPARATOR
Intervention: White noise
Number of subjects: 29
Study: 15895330

Group type: EXPERIMENTAL
Intervention: Wearing shoes with 1.5-in high heels
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control shoes without any additional heel
Number of subjects: 49
Study: 17413092

Group type: EXPERIMENTAL
Intervention: High physical activity (HPA) treatment with a goal of 2500 kcal/wk
Number of subjects: 202

Group type: COMPARATOR
Intervention: Standard behavioral treatment (SBT) with an exercise goal of 1000 kcal/wk
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Participants sustaining high exercise levels (>2500 kcal/wk)
Number of subjects: 202

Group type: COMPARATOR
Intervention: Participants exercising less than 2500 kcal/wk
Number of subjects: 202
Study: 10831015

Group type: EXPERIMENTAL
Intervention: Risperidone (RP)
Number of subjects: 184

Group type: COMPARATOR
Intervention: Conventional neuroleptics (CNs)
Number of subjects: 184
Study: 8842574

Group type: EXPERIMENTAL
Intervention: High-intensity resistance training (80% of 1-RM for 7 repetitions, 3 days/week for 52 weeks)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low-intensity resistance training (40% of 1-RM for 14 repetitions, 3 days/week for 52 weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no specified intervention)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-intensity resistance training
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low-intensity resistance training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 1538178

Group type: EXPERIMENTAL
Intervention: Iontophoresed morphine HCl
Number of subjects: 38

Group type: COMPARATOR
Intervention: Iontophoresed lactated ringers solution
Number of subjects: 38
Study: 6434024

Group type: EXPERIMENTAL
Intervention: Combined oral plus nasal beclomethasone diproprionate
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 30227772

Group type: EXPERIMENTAL
Intervention: Drug-eluting balloon
Number of subjects: 132

Group type: COMPARATOR
Intervention: Sham (uncoated balloon)
Number of subjects: 132
Study: 29752853

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 1 mcg kg‐1
Number of subjects: 60

Group type: COMPARATOR
Intervention: Normal saline solution (control)
Number of subjects: 60
Study: 26350351

Group type: EXPERIMENTAL
Intervention: Goserelin 10.8 mg (3-monthly)
Number of subjects: 222

Group type: COMPARATOR
Intervention: Goserelin 3.6 mg (monthly)
Number of subjects: 222
Study: 24660763

Group type: EXPERIMENTAL
Intervention: Carbonyl iron (45 mg daily)
Number of subjects: 282

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 282
Study: 22153875

Group type: EXPERIMENTAL
Intervention: Clinical plus simulator training (group 1, n = 10)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Simulator training only (group 3, n = 9)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Clinical training only (group 2, n = 9)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 28

Group type: COMPARATOR
Intervention: Group 1 vs Group 3
Number of subjects: 28
Study: 19884264

Group type: EXPERIMENTAL
Intervention: Raloxifene 60 mg daily for 12 months
Number of subjects: 198

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 198
Study: 18020541

Group type: EXPERIMENTAL
Intervention: Transdermal drug delivery system (TDDS) of metoprolol tartrate applied for 48 hours
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional marketed tablet of metoprolol tartrate (100 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Transdermal drug delivery system (TDDS) of metoprolol tartrate
Number of subjects: 0
Study: 16173330

Group type: EXPERIMENTAL
Intervention: Enhanced Intervention (EI)
Number of subjects: 242

Group type: COMPARATOR
Intervention: Standard Intervention (SI)
Number of subjects: 242
Study: 12474653

Group type: EXPERIMENTAL
Intervention: Magnesium sulfate (MgSO4) used as an adjuvant to anesthetics; shock-dose injection of 30-50 mg/kg and continual infusion at 500 mg/h for 20 hours.
Number of subjects: 20
Study: 10631832

Group type: EXPERIMENTAL
Intervention: Dipivefrine 0.1%
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 7722125

Group type: COMPARATOR
Intervention: Adenosine infusion alone
Number of subjects: 407

Group type: EXPERIMENTAL
Intervention: Adenosine with submaximal exercise
Number of subjects: 407

Group type: EXPERIMENTAL
Intervention: Symptom‐limited exercise with continuous adenosine
Number of subjects: 407
Study: 30307636

Group type: EXPERIMENTAL
Intervention: Upper cervical mobilisations and neck motor control and stabilisation exercises for 5 weeks
Number of subjects: 61

Group type: COMPARATOR
Intervention: No treatment (Control Group)
Number of subjects: 61
Study: 28508455

Group type: COMPARATOR
Intervention: Alpha-blocker only (n=111)
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Combination therapy (alpha-blocker + anticholinergic, n=110)
Number of subjects: 221
Study: 26507709

Group type: EXPERIMENTAL
Intervention: Timothy grass SLIT tablet
Number of subjects: 1140

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1140
Study: 23628617

Group type: EXPERIMENTAL
Intervention: Lixisenatide 20 μg
Number of subjects: 495

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 495
Study: 21285132

Group type: EXPERIMENTAL
Intervention: Adjuvant trastuzumab
Number of subjects: 197

Group type: COMPARATOR
Intervention: Control
Number of subjects: 197
Study: 18392221

Group type: EXPERIMENTAL
Intervention: Radioimmunoscintigraphy (RIS) using monoclonal antibody against human milk fat globule labeled with technetium-99m (99m)Tc
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: (99m)Tc-sestamibi ((99m)Tc-S)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Thallium-201 chloride ((201)TlCl)
Number of subjects: 74
Study: 15770636

Group type: EXPERIMENTAL
Intervention: Multi-component behavior-change intervention
Number of subjects: 267
Study: 14534715

Group type: EXPERIMENTAL
Intervention: beta-carotene (75 mg/day for 3-month cycles with one month intercycle intervals for 3 years)
Number of subjects: 214
Study: 9890390

Group type: EXPERIMENTAL
Intervention: Ginkor Fort (Ginkgo biloba extract, troxerutine, and heptaminol)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 8894998

Group type: EXPERIMENTAL
Intervention: Routine air evacuation method (Group 1)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Air evacuation method controlled with a Doppler ultrasonic probe (Group 2)
Number of subjects: 42